FFA
ASND icon

Farther Finance Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Farther Finance Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$139K Buy
+609
New +$154K ﹤0.01% 2590
2026
Q2 		– Sell
-635
Closed -$145K – 5986
2026
Q1 		$145K Buy
635
+85
+15% +$19.1K ﹤0.01% 2247
2025
Q4 		$117K Buy
550
+72
+15% +$14.9K ﹤0.01% 2238
2025
Q3 		$95K Buy
478
+256
+115% +$47.7K ﹤0.01% 2065
2025
Q2 		$38.3K Buy
222
+56
+34% +$9.12K ﹤0.01% 2273
2025
Q1 		$25.1K Sell
166
-22
-12% -$3.14K ﹤0.01% 2267
2024
Q4 		$25.9K Buy
188
+33
+21% +$4.34K ﹤0.01% 1975
2024
Q3 		$23.1K Hold
155
– – ﹤0.01% 2016
2024
Q2 		$20.8K Hold
155
– – ﹤0.01% 1765
2024
Q1 		$23.6K Buy
+155
New +$22.1K ﹤0.01% 1438

Other funds holding ASND

SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Farther Finance Advisors's ASND Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 609 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #2590 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in ASND as recently as Q1 2026.

Farther Finance Advisors first reported a position in ASND in Q1 2024 and has held it in 10 quarters since. The position peaked at $145K in Q1 2026. 10 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Farther Finance Advisors held 609 shares of Ascendis Pharma A/S worth $139K as of Q3 2026.
  • Ascendis Pharma A/S was a new Farther Finance Advisors position in Q3 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2590 holding.
  • Farther Finance Advisors first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 10 quarters since.
  • Farther Finance Advisors's Ascendis Pharma A/S position peaked at $145K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.